Scientists say study findings indicate that TC IV cells may represent a therapeutic target for the treatment of ...

Ever the optimist, Musk admits some of his claims “should be taken with a grain of salt.” Tesla will start production of ...

To address this challenge, CTMC has established a patient material bank, enabling early-stage process development with clinically relevant samples. This resource also supports continuous process ...

BCB-276 has earned regenerative medicine advanced therapy designation from the FDA in diffuse intrinsic pontine glioma, an ...

Rising prevalence, aging populations, and therapeutic innovation are reshaping the landscape of multiple myeloma care and ...

CAR-T-cell therapies can be highly effective cancer treatments, but some recipients have reported long-term difficulties with ...

Canadian firm INKAS can take your fourth-generation Tacoma to BR6 protection against 7.62-mm rounds and DM51-style grenade ...

When it comes to relapsed/refractory follicular lymphoma, chimeric antigen receptor (CAR) T-cell therapy has become a go-to ...

Ciara Freeman, MD, PhD, discusses the challenges of incorporating anito-cel into the treatment protocol for patients with multiple myeloma.

Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.